Common SNPs in aggregate appear to explain25–40% of liability to BP and current studies suggest that rare variants and gene–gene interactions explain substantial fractions of the remaining genetic contribution to BPD risk
Common SNPs in aggregate appear to explain25–40% of liability to BP and current studies suggest that rare variants and gene–gene interactions explain substantial fractions of the remaining genetic contribution to BPD risk